Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.

Breast cancer research and treatment - 1 Feb 2013

Borgquist Signe, Hjertberg Maria, Henningson Maria, Ingvar Christian, Rose Carsten, Jernström Helena

Abstract excerpt

The role of estrogen receptor beta (ERβ) in breast cancer has been investigated since its identification in 1996. Studies based on protein expression have indicated that ERβ is a favorable prognostic marker. Further, ERβ expression is lower in obese breast cancer patients. Fewer studies have focused on the prognostic impact of ERβ polymorphisms. Therefore, we analyzed the associations between four previously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Body Weights and Measures

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Estrogen Receptor beta

Share to Gene Dosage

Share to Gene Order

Share to Neoplasm Grading

Share to Tumor Burden

Source

Identifiers

PMID: 23274843
DOI: 10.1007/s10549-012-2367-z

Genes

ESR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.PMID 23274843Read ↗

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.Semantic proximity Read ↗

ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk.Semantic proximity Read ↗

Haplotypes of the estrogen receptor beta gene and breast cancer risk.Semantic proximity Read ↗

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.Semantic proximity Read ↗

A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.Semantic proximity Read ↗

Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.Semantic proximity Read ↗

Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer.Semantic proximity Read ↗

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.Semantic proximity Read ↗

Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.Semantic proximity Read ↗

Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients.Semantic proximity Read ↗

Estrogen Receptor Alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in Pashtun population of Khyber PakhtunkhwaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.